
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (18): 2294-2300.DOI: 10.12114/j.issn.1007-9572.2024.0261
Special Issue: 心血管最新文章合辑; 心肌梗死最新文章合辑
• Frontiers of Medicine • Previous Articles Next Articles
Received:2024-05-20
Revised:2024-09-27
Published:2025-06-20
Online:2025-04-25
Contact:
HE Guixin
通讯作者:
何贵新
作者简介:作者贡献:
朱子一负责文章的构思与设计、论文撰写;何贵新、秦伟彬负责论文修订、文章的质量控制及审校、对文章整体负责,监督管理;朱子一、宋惠、张利文、唐伟智、杨斐斐、刘凌云、欧阳彬负责研究资料的收集与整理。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0261
| [1] |
马丽媛,王增武,樊静,等. 《中国心血管健康与疾病报告2022》要点解读[J]. 中国全科医学,2023,26(32):3975-3994. DOI:10.12114/j.issn.1007-9572.2023.0408.
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
袁文慧,刘剑芳,王梦龙,等. 心血管疾病中心肌纤维化与自噬的相关性研究进展[J]. 中国心血管病研究,2017,15(3):197-200. DOI:10.3969/j.issn.1672-5301.2017.03.002.
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
冯雨菲,何贵新,胡梦弦,等. 从线粒体功能障碍探讨心血管疾病作用机制及中药复方干预治疗研究进展[J]. 辽宁中医药大学学报,2022,24(4):97-102. DOI:10.13194/j.issn.1673-842x.2022.04.021.
|
| [10] |
|
| [11] |
|
| [12] |
殷玉,许志亮,刘刚. 线粒体自噬在纤维化疾病中作用的研究进展[J]. 中华实用诊断与治疗杂志,2022,36(1):102-105. DOI:10.13507/j.issn.1674-3474.2022.01.025.
|
| [13] |
|
| [14] |
李开,饶莉. 线粒体自噬的分子生物学过程及其在心脏疾病中的作用[J]. 心血管病学进展,2022,43(3):222-224,228. DOI:10.16806/j.cnki.issn.1004-3934.2022.03.008.
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
刘亦伟,周静,高峰. 心肌梗死后心肌纤维化的发生机制、诊断及治疗的相关研究进展[J]. 智慧健康,2022,8(5):21-25. DOI:10.19335/j.cnki.2096-1219.2022.05.007.
|
| [19] |
|
| [20] |
李金城,杨杰,黄周,等. PINK1/Parkin通路调控线粒体自噬对大鼠急性心肌梗死细胞的影响研究[J]. 蛇志,2023,35(1):23-25,52. DOI:10.3969/j.issn.1001-5639.2023.01.006.
|
| [21] |
李伟,赵卓,赵添,等. 细胞自噬与心室重构的相关研究进展[J]. 心肺血管病杂志,2022,41(4):436-439. DOI:10.3969/j.issn.1007-5062.2022.04.021.
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] | |
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
王永正,苏先华,林金. 白藜芦醇通过抑制SIRT3/β-catenin/PPARγ信号通路对急性心肌梗死大鼠心肌细胞凋亡的影响[J]. 四川中医,2021,39(8):39-42.
|
| [32] |
李想. 栝楼薤白半夏汤对心肌缺血再灌注损伤大鼠线粒体自噬及PINK1/Parkin通路作用机制研究[D]. 昆明:云南中医药大学,2020. DOI:10.27460/d.cnki.gyzyc.2020.000296.
|
| [33] |
|
| [34] |
|
| [35] |
张文静,李晓峰,孙明明,等. 线粒体自噬在心肌梗死中的作用及研究进展[J]. 中华全科医学,2022,20(7):1194-1198. DOI:10.16766/j.cnki.issn.1674-4152.002556.
|
| [36] |
|
| [37] |
|
| [38] |
郑霞. 线粒体靶向性H2S供体AP39通过抑制过度线粒体自噬改善心肌梗死大鼠心肌纤维化[D]. 衡阳:南华大学,2021.
|
| [39] |
|
| [40] |
王春淼. 参莲提取物通过调控线粒体自噬干预炎症小体活化抗大鼠心肌梗死的研究[D]. 北京:中国中医科学院,2021. DOI:10.27658/d.cnki.gzzyy.2021.000098.
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
辛高杰. 双参宁心胶囊调控FUNDC1介导的线粒体自噬保护心肌缺血再灌注损伤机制研究[D]. 北京:中国中医科学院,2020. DOI:10.27658/d.cnki.gzzyy.2020.000191.
|
| [48] |
|
| [49] |
|
| [50] |
吴云娇,黄锋,卢创宏,等. HMGB1介导线粒体自噬参与糖尿病小鼠心肌缺血/再灌注损伤[J]. 广西医科大学学报,2021,38(4):655-661. DOI:10.16190/j.cnki.45-1211/r.2021.04.005.
|
| [51] |
|
| [52] | |
| [53] |
吴瑛滢,陈竞纬. 自噬在心血管疾病中的影响及中药的干预作用[J]. 实用中西医结合临床,2017,17(7):160-162. DOI:10.13638/j.issn.1671-4040.2017.07.104.
|
| [54] |
黄淑敏,李书楠,钟森杰,等. 基于"正邪理论"探讨自噬在慢性心力衰竭发展中的作用[J]. 中国实验方剂学杂志,2022,28(12):233-239. DOI:10.13422/j.cnki.syfjx.20221296.
|
| [55] |
周家谭,卢健棋,罗文宽,等. 中医药调控线粒体自噬相关信号通路防治心力衰竭的研究进展[J]. 广西中医药大学学报,2023,26(4):66-70. DOI:10.3969/j.issn.2095-4441.2023.04.018.
|
| [56] |
王新宇. 线粒体自噬-NLRP3炎症小体轴介导丹酚酸B对心肌缺血损伤的保护作用[D]. 南京:南京中医药大学,2017.
|
| [57] |
齐苗苗. 黄芪甲苷通过PINK1/Parkin介导线粒体自噬改善心肌细胞氧化应激损伤的研究[D]. 兰州:兰州大学,2021. DOI:10.27204/d.cnki.glzhu.2021.002986.
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
魏东明,徐臣年,刘洋,等. 积雪草苷通过Notch1/Hes1信号上调自噬减轻糖尿病心肌病心肌损伤的作用及机制[J]. 山西医科大学学报,2022,53(3):305-311. DOI:10.13753/j.issn.1007-6611.2022.03.008.
|
| [62] |
程相阁,刘万周,王东伟. 淫羊藿苷对心力衰竭大鼠线粒体自噬及能量代谢的影响[J]. 西北药学杂志,2022,37(4):51-57. DOI:10.3969/j.issn.1004-2407.2022.04.009.
|
| [63] |
|
| [64] |
汪刘洋. 芪参益气滴丸通过内源性H2S调控PINK1/Parkin介导的线粒体自噬抑制铁死亡改善心肌梗死后心肌纤维化[D]. 衡阳:南华大学,2023.
|
| [65] |
赵新军,黎燚华,康亮,等. 金欣康颗粒提高线粒体自噬蛋白LC3/Beclin1表达改善心力衰竭大鼠心肌纤维化的研究[J]. 中药新药与临床药理,2023,34(6):713-721. DOI:10.19378/j.issn.1003-9783.2023.06.001.
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
李亭亭,陈捷,吉恩生,等. 当归补血汤含药血清对间歇性低氧暴露H9c2心肌细胞损伤的作用及机制[J]. 中国中药杂志,2023,48(21):5881-5887. DOI:10.19540/j.cnki.cjcmm.20230614.703.
|
| [1] | LI Jing, LIU Ziqi, QIAN Li, YAO Ruiqin. Research Progress on the Role of the Microbiota-gut-brain Axis in Epilepsy [J]. Chinese General Practice, 2026, 29(32): 4821-4826. |
| [2] | WANG Shiyi, FAN Xiaojing, SI Yafei, ZHOU Zhongliang. Advances in Key Measurement Techniques for the Intrinsic Capacity of Elderly in the Context of Healthy Aging [J]. Chinese General Practice, 2026, 29(31): 4662-4666. |
| [3] | SU Die, ZHANG Yan, CHEN Xiaosong, HAN Yuxia, YAN Yongbin, DUAN Junya, CHEN Xinying, ZHAO Chenghao. Outcome Measures in Randomized Controlled Trials of Traditional Chinese Medicine for Refractory Mycoplasma Pneumoniae Pneumonia in Children [J]. Chinese General Practice, 2026, 29(31): 4609-4618. |
| [4] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [5] | ZHAO Jiayi, FAN Jian, YU Dehua. The Current Situation, Challenges, and Coping Strategies of Preserving Ratio Impaired Spirometry [J]. Chinese General Practice, 2026, 29(30): 4366-4371. |
| [6] | LI Xiling, ZHANG Fan, YANG Xinyue, YANG Heng. Application of Exercise Snacks in Chronic Disease Management: a Scoping Review [J]. Chinese General Practice, 2026, 29(30): 4472-4479. |
| [7] | LI Hangzhi, WANG Jiepeng, ZHANG Xiaoyi, FANG Chaoyi. Epidemiology and Comorbidities of Insomnia: Research Advances from an Integrated Chinese and Western Medical Perspective [J]. Chinese General Practice, 2026, 29(30): 4463-4471. |
| [8] | WANG Sixue, YUAN Yue, XIONG Lisha, ZHOU Chunyi, YUAN Xiangqing, FANG Xuelian, ZHANG Ailin, WANG Yuncui. Development of the Traditional Chinese Medicine Health Behaviors Stage-specific Influencing Factors Scale and Its Reliability and Validity Testing [J]. Chinese General Practice, 2026, 29(29): 4337-4344. |
| [9] | CHEN Yujing, WANG Yan, LI Guang, DONG Benchao, YANG Peichuan, MA Jianxiong. Digital Technologies in the Management of Sarcopenia among Older Adults in Asia: a Scoping Review [J]. Chinese General Practice, 2026, 29(29): 4200-4210. |
| [10] | XIE Xiaoyun, LIU Chenxi, LIU Yushu, ZHOU Yihan. Artificial Intelligence Research Practices in Primary Healthcare Institutions in China and the Potential Issue of Data Poverty: a Scoping Review [J]. Chinese General Practice, 2026, 29(28): 4067-4077. |
| [11] | JIANG Yanlin, WANG Zhe, ZHAI Rui, ZHANG Mengjie, CHEN Xi, WANG Junhong. Screening Optimal Traditional Chinese Medicine Compound Formulas for ADHD Treatment: a Study Integrating Network Meta-analysis and Entropy-weighted TOPSIS Method [J]. Chinese General Practice, 2026, 29(27): 3985-3994. |
| [12] | YANG Zhaoheng, DANG Yuan, SHI Muran, LI Wenxin, ZHAO Yimo, WANG Zihan, WU Ning. Development of Primary Care Traditional Chinese Medicine Workforce in China: a Policy Analysis Using the Three-dimensional "Theme-instrument-evaluation" Framework [J]. Chinese General Practice, 2026, 29(27): 3906-3914. |
| [13] | FENG Yachen, LIU Lewei, XUE Jinyue, SUN Xianlin, LIU Huanzhong. Research Progress of Wearable Technology in the Diagnosis and Treatment of Mental Disorders [J]. Chinese General Practice, 2026, 29(27): 4016-4025. |
| [14] | DU Ruofang, CAO Yang, LIU Dianna, ZHANG Qixin, WANG Xiaofan, SHI Enze, ZHANG Yuxin, LI Quanwang. A 10-Year Clinical Review of Raw Pinelliae Rhizoma in Tumor Treatment: Usage Patterns and Safety Evaluation [J]. Chinese General Practice, 2026, 29(27): 3995-4003. |
| [15] | YUAN Yue, WANG Sixue, YUAN Xiangqing, ZHOU Chunyi, XIONG Lisha, ZHANG Ailin, FANG Xuelian, WANG Yuncui. Development Reliability Validity Test of Traditional Chinese Medicine Health Behaviors Scale [J]. Chinese General Practice, 2026, 29(26): 3865-3872. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||